James A Burke

This inventor holds 50 USPTO granted patents and 21 published patent applications, plus 6 CIPO patents and 15 EPO patents, primarily in Ocular Drug Delivery. Top assignees: Allergan, Inc., Allergan Sales, Inc., Other. Active years: 1987-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: James A Burke. Retrieved from https://idiyas.com/inventor/james-a-burke

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 50 (Patent Applications = 21)

% Patents Active = 80.0

CIPO Patents = 6 (Patent Applications = 4)

EPO Patents = 15 (Patent Applications = 21)

Average Co-Inventor Count = 3.1

ph-index = 18

Forward Citations = 771(Granted Patents)

Location History:

Galloway, OH (US) (1987)
Tustin, CA (US) (1991 - 2001)
Santa Ana, CA (US) (2001 - 2023)

Company Filing History:

1 out of 834,601

Other

patents

Years Active: 1987-2026

Loading Chart...

Areas of Expertise:

Sodium Chlorite

Antimicrobial Efficacy

Biodegradable Drug Delivery

Sustained Release

Intracameral Implants

Ocular Therapy

Alpha-2 Agonist

Retinal Dysfunction

Therapeutic Agents

Vision Improvement

Drug Delivery Systems

Imidazoles

50 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12527816 - Sodium chlorite compositions with enhanced anti-microbial efficacy and reduced toxicity (2026-01-20),

2. 11738043 - Sodium chlorite compositions with enhanced antimicrobial efficacy and reduced toxicity (2023-08-29),

3. 11096958 - Sodium chlorite compositions with enhanced anti-microbial efficacy and reduced toxicity (2021-08-24),

4. 10653621 - Biodegradable drug delivery systems for the sustained release of proteins (2020-05-19),

5. 10363214 - Method for treating atrophic age related macular degeneration (2019-07-30),

6. 10278919 - Intracameral sustained release therapeutic agent implants (2019-05-07),

7. 10201641 - Sustained release intraocular implants and methods for treating ocular vasculopathies (2019-02-12),

8. 9572859 - Compositions and methods for localized therapy of the eye (2017-02-21),

9. 9504696 - Intracameral sustained release therapeutic agent implants (2016-11-29),

10. 9161938 - Sustained release intraocular implants and methods for treating ocular vasculopathies (2015-10-20),

11. 9144543 - Sustained release intraocular implants and methods for preventing retinal dysfunction (2015-09-29),

12. 9061065 - Intracameral sustained release therapeutic agent implants (2015-06-23),

13. 8956655 - Biodegradable drug delivery system (2015-02-17),

14. 8821870 - Method for treating atrophic age related macular degeneration (2014-09-02),

15. 8647659 - Intracameral sustained release therapeutic agent implants (2014-02-11),

Title: The Innovative Journey of James A. Burke

Introduction: James A. Burke, a pioneering inventor based in Santa Ana, CA, has made significant contributions to the field of technology with his groundbreaking inventions and patents.

Latest Patents: James A. Burke holds several patents in various technological domains, including advancements in renewable energy systems, artificial intelligence algorithms, and medical devices.

Career Highlights: Throughout his illustrious career, James A. Burke has been recognized for his innovative spirit and problem-solving abilities. His inventions have revolutionized industries and improved the quality of life for many.

Collaborations: James A. Burke has collaborated with leading research institutions, universities, and tech companies to further develop and commercialize his inventions. His partnerships have led to the successful implementation of cutting-edge technologies in real-world applications.

Conclusion: James A. Burke's dedication to innovation and his relentless pursuit of excellence have solidified his reputation as a visionary inventor. His impact on the technological landscape is profound, and his legacy continues to inspire future generations of inventors.

Profile summary based on public USPTO records.